Literature DB >> 18977052

Fatty acid binding proteins in adipose tissue: a promising link between metabolic syndrome and atherosclerosis?

Eva Krusinová1, Terezie Pelikánová.   

Abstract

Adipocyte/macrophage fatty acid binding protein (A-FABP) has been shown to be closely associated with metabolic syndrome, obesity and development of atherosclerosis. Moreover, A-FABP has been recently suggested as a potential therapeutic target of these abnormalities in animal models. The present review aims to summarize current knowledge on A-FABP functions and regulations both in animal models and humans, since the role of A-FABP in human physiology and disease has not been presently clarified.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18977052     DOI： 10.1016/j.diabres.2008.09.023

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  20 in total

1.  Structural analysis of ibuprofen binding to human adipocyte fatty-acid binding protein (FABP4).

Authors:  Javier M González; S Zoë Fisher
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-01-28       Impact factor: 1.056

2.  [Anatomical heterogeneity in the proteome of human subcutaneous adipose tissue].

Authors:  G A Martos-Moreno; L Sackmann-Sala; D E Berryman; D W Blome; J Argente; J J Kopchick
Journal:  An Pediatr (Barc)       Date:  2012-11-24       Impact factor: 1.500

3.  Serum adipocyte fatty acid-binding protein level is associated with arterial stiffness quantified with cardio-ankle vascular index in kidney transplant patients.

Authors:  Yen-Cheng Chen; Bang-Gee Hsu; Chung-Jen Lee; Ching-Chun Ho; Guan-Jin Ho; Ming-Che Lee
Journal:  Clin Exp Nephrol       Date:  2017-06-28       Impact factor: 2.801

4.  Plasma levels of FABP4, but not FABP3, are associated with increased risk of diabetes.

Authors:  Luc Djoussé; J Michael Gaziano
Journal:  Lipids       Date:  2012-06-16       Impact factor: 1.880

Review 5.  Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.

Authors:  Yu Wang
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

6.  Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells.

Authors:  Mary Yk Lee; Huiying Li; Yang Xiao; Zhiguang Zhou; Aimin Xu; Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

7.  Using neonatal skin to study the developmental programming of aging.

Authors:  Leryn J Reynolds; Brett J Dickens; Benjamin B Green; Carmen J Marsit; Kevin J Pearson
Journal:  Exp Gerontol       Date:  2016-12-27       Impact factor: 4.032

8.  Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue.

Authors:  Wentao Chen; Jiajia Dong; Lars Plate; David E Mortenson; Gabriel J Brighty; Suhua Li; Yu Liu; Andrea Galmozzi; Peter S Lee; Jonathan J Hulce; Benjamin F Cravatt; Enrique Saez; Evan T Powers; Ian A Wilson; K Barry Sharpless; Jeffery W Kelly
Journal:  J Am Chem Soc       Date:  2016-06-02       Impact factor: 15.419

9.  Cellular and molecular comparison of redifferentiation of intramuscular- and visceral-adipocyte derived progeny cells.

Authors:  Jie Chen; Michael V Dodson; Zhihua Jiang
Journal:  Int J Biol Sci       Date:  2010-01-21       Impact factor: 6.580

10.  A-FABP and oxidative stress underlie the impairment of endothelium-dependent relaxations to serotonin and the intima-medial thickening in the porcine coronary artery with regenerated endothelium.

Authors:  Calvin K Chan; Yingzi Zhao; Song Yan Liao; Yue Lin Zhang; Mary Y K Lee; Aimin Xu; Hung Fat Tse; Paul M Vanhoutte
Journal:  ACS Chem Neurosci       Date:  2012-09-22       Impact factor: 4.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.